Tissue Regenix Group Balance Sheet Health
Financial Health criteria checks 5/6
Tissue Regenix Group has a total shareholder equity of $29.4M and total debt of $6.0M, which brings its debt-to-equity ratio to 20.4%. Its total assets and total liabilities are $43.2M and $13.9M respectively.
Key information
20.4%
Debt to equity ratio
US$5.99m
Debt
| Interest coverage ratio | n/a |
| Cash | US$4.65m |
| Equity | US$29.36m |
| Total liabilities | US$13.89m |
| Total assets | US$43.24m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TRX's short term assets ($19.1M) exceed its short term liabilities ($4.7M).
Long Term Liabilities: TRX's short term assets ($19.1M) exceed its long term liabilities ($9.2M).
Debt to Equity History and Analysis
Debt Level: TRX's net debt to equity ratio (4.5%) is considered satisfactory.
Reducing Debt: TRX's debt to equity ratio has increased from 0% to 20.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable TRX has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: TRX is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 30.3% per year.